Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Announce Positive PHALCON-EE Study Results Of...
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) announced that vonoprazan met the primary endpoints and core secondary superiority endpoints in PHALCON-EE, a vital third phase study...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Aion Therapeutic Inc. (CNSX:AION) Confirms Management Appointment Amid Debentures Restructuring
Formerly known Osoyoos Cannabis Inc., Aion Therapeutic Inc. (CNSX:AION) researches, grows, and markets medical cannabis in Canada. The company has carried out a number...
MAKE IT MODERN
LATEST REVIEWS
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Releases Final Phase 3 ClarlDHy TIBSOVO® Study...
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) has announced final overall survival analysis results from its Phase 3 ClarlDHy TIBSOVO® trial in cholangiocarcinoma patients have received prior...
MAKE IT MODERN
PERFORMANCE TRAINING
Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated With Sumifilam
Cassava Sciences Inc. (NASDAQ:SAVA) has announced the final results of its Phase 2b study of sumifilam, its novel drug candidate in Alzheimer’s disease.
Cassava Sciences...
Pluristem Therapeutics Inc. (NASDAQ: PSTI) Announces Topline Second Phase Dose Escalation Study Evaluating PLX-PAD...
Pluristem Therapeutics Inc. (NASDAQ: PSTI) has released topline findings from phase 2 dose-escalation trials evaluating the efficacy and safety of intramuscular PLX-PAD cells injection...
Bitcoin is Back in Rally Mode, and these Stocks Stand to Benefit Most (RIOT,...
Bitcoin is back in gear this week with a major bullish technical breakout on Monday that takes BTC to new year-to-date highs...
Nova Mentis Life Science Corp (OTCMKTS: NMLSF) to File for a Provisional Patent to...
Nova Mentis Life Science Corp wants to develop wide-ranging substances. They include tryptamine analogues, psilocybin, aeruginascin, and baeocystin. It seems to have made a significant...
Maravai LifeSceinces Holdings Inc. (NASDAQ: MRVI) Reports 364% YoY Revenue Growth In Q2 2021
Maravai LifeSceinces Holdings Inc. (NASDAQ: MRVI) has announced its Q2 2021 financial results for the period ending June 30, 2021, and offered its business...
MAKE IT MODERN
